Graphene Nanochem Regulatory News (GRPH)

9 Feb 2007 14:41

Biofutures International plc09 February 2007 For Immediate Release 9 February 2007 Biofutures International plc ("Biofutures") Appointment of Non-Executive Director Christopher John Dennison, aged 53, has been appointed non-executive director ofBiofutures with immediate effect. Chris has 15 years' experience of working atboard level in global companies to support major strategic and business modelchanges. This has included strategic developments in all areas of the oil, gasand petrochemical industry in different cultural environments. Clients haveincluded BP, Shell, BG, Electrocomponents, Amec and Bristow Helicopters. He is apharmacologist by background and was a founding partner of Bywater Limited, thestrategy consultancy which merged with Axon in 2003 (a UK listed managementconsultancy with operations in Europe, USA, Middle East and Far East) and isstill with Axon. He occasionally lectures on Strategy on the MBA courses atOxford & Pepperdine. The following is a list of all directorships/partnerships or other businessinterests (e.g. sole trader or firm) held by Chris during the past five years: Current Directorships Past Directorships----------------------- --------------------Bywater Limited Performance Events Ltd-----------------Bywater Technology Limited Stretch Performance Network LtdClarenbridge Limited There are no further details in relation to the above appointment which requiresdisclosure under paragraph (g) of Schedule 2 of the AIM Rules. For further information please contact: Nicholas Gee: Executive ChairmanBiofutures International Plc 020 7466 5000 Joseph Marffy/Roxane MarffyRuegg & Co Limited 020 7584 3663 Daniel Briggs/Jeremy ChantryHichens Harrison & Co plc 020 7382 7776 Mark Edwards/Suzanne Brocks 0207 466 5000Buchanan Communications This information is provided by RNS The company news service from the London Stock Exchange